Will Morgan Stanley repurchase at least $7.5B of common stock cumulatively across Q1-Q3 2026?
Current Prediction
Prediction Distribution
Individual Predictions(9 runs)
Q1 buyback $1.75B leaves $5.75B required across Q2+Q3 ($2.875B/qtr) — a 64% step-up from Q1. Pick is methodical, not aggressive. Stock at $194.59 52-week high reduces management's appetite to lean. Basel III finalization in H2 2026 favors capital reservation. Lean NO at 28%.
Tail-risk frame: a Q2 stock pullback (5-10%) could reset management's view and trigger an opportunistic ramp; German bank reorg's $100B+ migration largely complete in Q1 frees Q2-Q3 RWA capacity; 300+ bps CET1 buffer ample. These three could collectively push acceleration. Slightly higher tail at 32%.
Historical base rate: when a CEO publicly frames buybacks as 'opportunistic' and misses a single-quarter target, sequential ramp clearing aggregate 64% above Q1 happens ~25% of the time. Pick's discipline is institutional. Lean NO firm.
$7.5B target requires $2.5B/qtr average. Q1 was $1.75B. Need 43% acceleration. Probability ~30% given Pick's conservative posture.
Modest probability of ramp; Q2 alone could absorb $2.5B if the German reorg is fully behind, but Q3 also needs to step up. Around 32%.
Direct math: Q1 $1.75B + Q2 $2.0B + Q3 $2.0B = $5.75B (well below $7.5B). Even with each quarter ramping to $2.25B average, only $6.25B. Strong NO at 28%.
Big step-up required from disciplined CEO. Lean NO at 30%.
Q1 sub-trip-wire signals continued discipline. NO at 27%.
Math is hard; Pick won't lean at 52-wk high. NO at 28%.
Resolution Criteria
Resolves YES if Morgan Stanley's cumulative common stock repurchases for Q1 + Q2 + Q3 2026, as disclosed across the Q1, Q2, and Q3 2026 earnings releases or 10-Qs, total at least $7.5B. Resolves NO otherwise.
Resolution Source
Morgan Stanley Q1, Q2, and Q3 2026 earnings press releases and 10-Q filings
Source Trigger
Capital deployment pace — does Morgan Stanley accelerate buyback materially through 2026 against 300bps excess CET1 buffer
Full multi-lens equity analysis